These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27765282)

  • 1. Fibrous dysplasia. Clinical review and therapeutic management.
    Florez H; Peris P; Guañabens N
    Med Clin (Barc); 2016 Dec; 147(12):547-553. PubMed ID: 27765282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate therapy for fibrous dysplasia.
    DiMeglio LA
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():440-5. PubMed ID: 17982393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bisphosphonates in the therapy of fibrous dysplasia. Relevant data and practical aspects].
    Egner-Höbarth S; Welkerling H; Windhager R
    Orthopade; 2007 Feb; 36(2):124, 126-30. PubMed ID: 17277960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramedullary rodding and bisphosphonate treatment of polyostotic fibrous dysplasia associated with the McCune-Albright syndrome.
    O'Sullivan M; Zacharin M
    J Pediatr Orthop; 2002; 22(2):255-60. PubMed ID: 11856942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrous dysplasia of bone and McCune-Albright syndrome.
    Chapurlat RD; Orcel P
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):55-69. PubMed ID: 18328981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of antiresorptive agents in fibrous dysplasia and McCune Albright syndrome, a systematic review and meta-analysis.
    Bertin H; Moussa MS; Komarova S
    Rev Endocr Metab Disord; 2023 Dec; 24(6):1103-1119. PubMed ID: 37632645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome.
    Lala R; Matarazzo P; Bertelloni S; Buzi F; Rigon F; de Sanctis C
    Acta Paediatr; 2000 Feb; 89(2):188-93. PubMed ID: 10709889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.
    Rotman M; Hamdy NAT; Appelman-Dijkstra NM
    Br J Clin Pharmacol; 2019 Jun; 85(6):1169-1179. PubMed ID: 30471134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrous dysplasia of bone in a young male].
    Alonso G; Muñoz-Torres M
    Endocrinol Nutr; 2009 Apr; 56(4):195-200. PubMed ID: 19627736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with denosumab for pelvic fibrous dysplasia: A case report and review of the literature.
    Ikuta K; Sakai T; Koike H; Ito K; Imagama S; Nishida Y
    Medicine (Baltimore); 2021 Dec; 100(49):e28138. PubMed ID: 34889277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome.
    Lala R; Matarazzo P; Andreo M; Marzari D; Bellone J; Corrias A; de Sanctis C;
    J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():583-93. PubMed ID: 16789621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome.
    Matarazzo P; Lala R; Masi G; Andreo M; Altare F; de Sanctis C
    J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():929-37. PubMed ID: 12199352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denosumab for craniofacial fibrous dysplasia: duration of efficacy and post-treatment effects.
    Raborn LN; Burke AB; Ebb DH; Collins MT; Kaban LB; Boyce AM
    Osteoporos Int; 2021 Sep; 32(9):1889-1893. PubMed ID: 33772327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pamidronate for fibrous dysplasia due to McCune Albright Syndrome.
    Kochar IP; Kulkarni KP
    Indian Pediatr; 2010 Jul; 47(7):633-5. PubMed ID: 20683120
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fibrous dysplasia].
    Rödl R; Götze C
    Orthopade; 2008 Jan; 37(1):49-55. PubMed ID: 18084739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate treatment in craniofacial fibrous dysplasia--a case report and review of the literature.
    Mäkitie AA; Törnwall J; Mäkitie O
    Clin Rheumatol; 2008 Jun; 27(6):809-12. PubMed ID: 18247080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate treatment of pediatric bone disease.
    Speiser PW; Clarson CL; Eugster EA; Kemp SF; Radovick S; Rogol AD; Wilson TA;
    Pediatr Endocrinol Rev; 2005 Dec; 3(2):87-96. PubMed ID: 16361982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrous dysplasia: overview].
    Akasbi N; Abourazzak FE; Talbi S; Tahiri L; Harzy T
    Pan Afr Med J; 2015; 21():21. PubMed ID: 26401215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of fibrous dysplasia: focus on denosumab.
    Huzum B; Antoniu S; Dragomir R
    Expert Opin Biol Ther; 2022 Mar; 22(3):397-405. PubMed ID: 34964677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical guidelines for the management of craniofacial fibrous dysplasia.
    Lee JS; FitzGibbon EJ; Chen YR; Kim HJ; Lustig LR; Akintoye SO; Collins MT; Kaban LB
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S2. PubMed ID: 22640797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.